Q3 2024 Axsome Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to the Axsome Therapeutics third-quarter 2024 financial results conference call. (Operator Instructions) Please note that today's call is being recorded.
I'll now turn the call over to Darren Opland, Director of Corporate Communications. Please go ahead, sir.
Thank you. Good morning, everyone, and thank you for joining our third quarter 2024 financial results conference call. I'm joined today by Dr. Herriot Tabuteau, Chief Executive Officer; Nick Pizzie, Chief Financial Officer; Mark Jacobson, Chief Operating Officer; and Ari Maizel, Chief Commercial Officer.
Earlier this morning, we posted a new corporate presentation complementing today's call to the Investors section of our website. Those joining via webcast may also advance through the slides at any time during the discussion.
As a reminder, we will be making certain forward-looking statements regarding, among other things, the efficacy, safety and intended utilization of our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |


